Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE
Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.
Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
FDA announces Class I recall of patches used for heart surgery
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.

M&A mergers and acquisitions business deal

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical.

Fewer stress tests, more high-risk procedures: How working at a hospital influences cardiologists

Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists.

Abbott completes $850M acquisition of Minnesota-based Cardiovascular Systems

The deal represents a significant addition to Abbott’s cardiovascular portfolio.

Florida-based network of outpatient vascular centers partners with 2 private equity investment firms

American Vascular Associates believes the new investments from Petra Capital Partners and Canopy Capital Partners should help it keep up with the rising demand of outpatient treatment options.

Medtronic’s Endurant stent graft system for EVAR linked to strong 10-year outcomes

Researchers examined 10-year follow-up data from approximately 400 EVAR patients, sharing their findings at the 2023 Charing Cross Symposium in London.

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

The AI-powered tool gained FDA clearance back in October 2022.

The variable fluorescence attenuation of blood has been a hindrance to near-infrared fluorescence (NIRF) measurements in cardiovascular imaging. Fortunately, researchers have devised an innovative correction method in which the guidewire (GW) is coated with the fluorescent agent (ICG) and used as a reference standard in each frame, leading to a much higher accuracy. Credit: Rauschendorfer et al., doi 10.1117/1.JBO.28.4.046001

New technique improves accuracy of near-infrared fluorescence imaging

NIRF imaging could help interventional cardiologists personalize care in the cath lab, but a key engineering issue needed to be solved first.

Vascular & Endovascular

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

Is IVL safe for patients with diabetes?

FDA announces Class I recall of patches used for heart surgery

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

IVC filter recalled due to injury risk